Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 16, 2022 Filed Sep 20, 2022 14:29 UTC |
Elson MarilynMs. Elson serves as CFO · 10% owner
OSSER LEONARDSpouse
|
PurchaseCommon Stock | 36,000 | $4.15 | $149,400.00 |
DisclosureSEC source: 0001829126-22-017010 · ownership.xml · nonDerivative · entry 1 Elson Marilyn · CIK 0001916491 · Ms. Elson serves as CFO · 10% owner OSSER LEONARD · CIK 0001188354 · Spouse Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 825,744 Read SEC document |
| September 16, 2022 Filed Sep 20, 2022 18:24 UTC |
Morad RickDirector
|
PurchaseCommon Stock | 2,500 | $4.15 | $10,375.00 |
DisclosureSEC source: 0001829126-22-017008 · ownership.xml · nonDerivative · entry 1 Morad Rick · CIK 0001916492 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,989 Read SEC document |
| September 16, 2022 Filed Sep 20, 2022 18:06 UTC |
Kazden AlanDirector
|
PurchaseCommon Stock | 2,500 | $4.15 | $10,375.00 |
DisclosureSEC source: 0001829126-22-017006 · ownership.xml · nonDerivative · entry 1 Kazden Alan · CIK 0001917765 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Owned by Alan and Natalie Kazden Family Trust Disclosed balance after: 89,131 F1 · ownership.nature: Reporting Person has dispositive and voting control of the shares. Read SEC document |
| September 16, 2022 Filed Sep 20, 2022 18:05 UTC |
Owens DavidDirector · Chief Medical Officer
|
PurchaseCommon Stock | 2,500 | $4.15 | $10,375.00 |
DisclosureSEC source: 0001829126-22-017005 · ownership.xml · nonDerivative · entry 1 Owens David · CIK 0001916664 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,174 Read SEC document |
| September 16, 2022 Filed Sep 20, 2022 18:05 UTC |
White MarkDirector · President/CEO
|
PurchaseCommon Stock | 2,500 | $4.15 | $10,375.00 |
DisclosureSEC source: 0001829126-22-017004 · ownership.xml · nonDerivative · entry 1 White Mark · CIK 0001916493 · Director · President/CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 289,627 Read SEC document |
| September 16, 2022 Filed Jun 30, 2023 19:15 UTC Amendment |
Morad RickDirector
|
PurchaseCommon Stock | 2,500 | $4.15 | $10,375.00 |
DisclosureSEC source: 0001829126-23-004520 · ownership.xml · nonDerivative · entry 1 Morad Rick · CIK 0001916492 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,341 Read SEC document |
| September 16, 2022 Filed Jun 30, 2023 19:15 UTC Amendment |
Kazden AlanDirector
|
PurchaseCommon Stock | 2,500 | $4.15 | $10,375.00 |
DisclosureSEC source: 0001829126-23-004518 · ownership.xml · nonDerivative · entry 1 Kazden Alan · CIK 0001917765 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Owned by Alan and Natalie Kazden Family Trust Disclosed balance after: 83,131 F1 · ownership.nature: Reporting Person has dispositive and voting control of the shares. Read SEC document |
| September 16, 2022 Filed Oct 5, 2023 16:09 UTC |
White MarkDirector · President/CEO
|
PurchaseCommon stock warrants · Derivative | 25,000 | $0.40 Strike: $4.15 | $10,000.00 |
DisclosureSEC source: 0001829126-23-006450 · ownership.xml · derivative · entry 1 White Mark · CIK 0001916493 · Director · President/CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2025-09-19 Read SEC document |
| September 16, 2022 Filed Oct 5, 2023 16:08 UTC |
Owens DavidDirector · Chief Medical Officer
|
PurchaseCommon stock warrants · Derivative | 2,500 | $0.40 Strike: $4.15 | $1,000.00 |
DisclosureSEC source: 0001829126-23-006449 · ownership.xml · derivative · entry 1 Owens David · CIK 0001916664 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2025-09-19 Read SEC document |
| September 16, 2022 Filed Oct 5, 2023 16:07 UTC |
Kazden AlanDirector
|
PurchaseCommon stock warrants · Derivative | 2,500 | $0.40 Strike: $4.15 | $1,000.00 |
DisclosureSEC source: 0001829126-23-006448 · ownership.xml · derivative · entry 1 Kazden Alan · CIK 0001917765 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2025-09-19 Read SEC document |
| September 15, 2022 Filed Sep 22, 2022 18:41 UTC Amendment |
White MarkDirector · President/CEO
|
PurchaseCommon Stock | 25,000 | $4.15 | $103,750.00 |
DisclosureSEC source: 0001829126-22-017065 · ownership.xml · nonDerivative · entry 1 White Mark · CIK 0001916493 · Director · President/CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 289,627 Read SEC document |
| September 15, 2022 Filed Jun 30, 2023 19:15 UTC Amendment |
White MarkDirector · President/CEO
|
PurchaseCommon Stock | 25,000 | $4.15 | $103,750.00 |
DisclosureSEC source: 0001829126-23-004519 · ownership.xml · nonDerivative · entry 1 White Mark · CIK 0001916493 · Director · President/CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 309,127 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.